Skip to main content

Table 2 Clinical phenotypes of 20 unilateral high myopia probands with molecular diagnostic testing

From: Clinical and genetic risk factors underlying severe consequence identified in 75 families with unilateral high myopia

Family

Sex

Age

First

VA (Snellen)

Refraction (SER)

AL (mm)

Fundus

OCT

FFA

Diagnosis information

ID

At onset

At exam

Symptom

OD

OS

OD

OS

OD

OS

OD

OS

 

OD

OS

Initial

Final

F1-II:1

F

3y4m

3y4m

PV on PE

0.1

0.2

− 9.5

− 2

23.78

21.95

TF;DCA;PS;PCC

N;

G1(OD)

/

/

uHM

STL

F2-II:2

M

5y10m

5y11m

PV on PE

1

0.05

0.75

− 14.75

23.1

29.22

N

TF;mild PCA;PCC

N

/

/

uHM

STL

F3-II:2

M

3y6m

4y7m

HM on PE

0.7

0.5

− 4.5

− 10.5

25.67

27.51

N

TF;DCA

/

/

/

uHM

STL

F4-II:1

F

3y3m

8y10m

PV on PE

0.6

0.3

− 5.75

− 13.75

24.96

27.93

N

TF;PCC

N

/

/

uHM

STL

F5-II:2

M

5y3m

5y5m

HM on PE

1

0.15

0.25

− 11.5

22.4

26.98

N

TF

N

/

/

uHM

STL

F6-II:2

M

5y2m

5y2m

HM on PE

0.8

0.04

1.5

− 12.25

22.68

27.83

N

FVH;TF;DCA;LD;PCD

G1(OS)

N

AZ;NV

uHM

STL

F7-II:2

F

5y4m

5y4m

PV on PE

FC

0.7

− 10

2

24.58

20.95

TF;RVs

N

N

/

/

uHM

MFS

F8-II:1

F

2y7m

3y7m

HM on PE

0.3

0.6

− 6.5

0

NA

NA

TF;PPA

N

/

/

/

uHM

MFS?

F9-II:1

F

EC

11y5m

Extropia

0.12

0.8

NA

NA

27.28

23.42

TF;DCA

N

 

AZ;NV;FL

AZ;NV;FL

uHM

FEVR

F10-II:1

M

2y9m

4y9m

MYP

0.5

0.4

− 2.75

− 10

24.54

27.38

TF;CC;LD

ODH;TF;DCA;LD;PCD

/

AZ;NV

AZ;NV

uHM

FEVR

F11-II:1

F

5y

6y1m

MYP

0.4

0.8

− 10

0.25

25.66

22.26

TF;Rvs;PCD

N;PCD

N

AZ;NV;FL

AZ;NV;FL

uHM

FEVR

F12-II:2

M

4y11m

5y3m

MYP

0.1

0.4

− 11.5

− 3.75

26.93

24.05

TF;DCA;PS;LD

TF;DCA;PS;PCD

G1(OU)

/

/

uHM

FEVR

F13-II:2

M

10m

4y10m

Photophobia

0.03

0.8

− 6

1.65

25.87

22.64

TF; ODH*

N

N

ME;AZ;NV;FL

AZ;NV;FL

uHM

FEVR

F14-II:1

F

1y4m

3y4m

HM on PE

0.2

0.4

− 8.75

− 2.5

24.38

22.45

TF;PPA:PCC

TF;PPA;PCC

/

/

/

uHM

CSNB1E

F15-II:2

F

6y3m

6y3m

PV on PE

0.03

1

− 12.25

− 0.25

NA

NA

TF;PPA;DCA

N

/

Hypo;Hype-AF#

Hyper-AF#

uHM

uHM

F16-II:2

F

7y8m

7y11m

PV on PE

1

0.1

0.5

− 8.5

23.45

26.82

TF;ODH;PPA

TF;DCA

N

/

/

uHM

uHM

F17-II:1

F

3y

4y4m

PV on PE

0.4

0.7

− 6

0.25

23.53

21.71

TF;PPA;PCC

PCC

N

/

/

uHM

OA1 carrier

F18-II:1

F

2y3m

4y3m

MYP

0.2

0.6

− 11.5

− 1

25.25

21.96

TF;PPA

N

G1(OU)

/

/

uHM

uHM

F19-II:1

M

4y6m

4y6m

EC-NYS

0.12

0.01

0.5

− 9

22.9

25.86

TF;FVH

TF;DCA;FVH

/

/

/

uHM

NYS1

F20-II:2

F

un

29y

HM on PE

0.5

HM#

− 4.75

− 15.12

24.13

30.2

TF; PPA

TF;PA;MA

N

/

/

uHM

CSNB2A carrier

  1. FFA fundus fluorescein angiography, OCT Optical coherence tomography, ERG The electroretinogram, VA Visual acuity, SER Spherical equivalent refractive errors, M Male, F Female;, N Normal, NA Not available, PE Poor eye, PV Poor vision, HM# Hand movement, FC Finger counting, HM high myopia, TF Tessellated fundus, PPA Myopic peripapillary crescent, PS Posterior staphyloma, DCA Diffuse chorioretinal atrophy, MA Macular atrophy, PA Patchy atrophty, RVs Retinal vessels straightening, FVH Foveal hypoplasia, LD Lattice degeneration, ODH Optic disc hypoplasia, ODT Optic disc tilt, PCD Peripheral retinal degeneration, PCC Peripheral retinal pigmentary change, AZ Avascular zone, NV Neovascularization, FL Fluorescein leakage, ME Macular ectopia, CC Chorioretinal coloboma, uHM unilateral high myopia, STL Stickler syndrome, MFS Marfan syndrome, CSNB1E complete congenital stationary night blindness, CSNB2A incomplete congenital stationary night blindness 2A, OA1 ocular albinism type I; NYS1 infantile nystagmus
  2. #The FFA images of the proband (F15-II:2) showed hypofluorescence in the entire crescent area of the right eye and hyperflourensce in the optic disc area of both eye